Sino Biopharmaceutical Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 26,199.41 million compared to CNY 26,026.16 million a year ago. Net income was CNY 2,331.94 million compared to CNY 2,543.57 million a year ago.

Basic earnings per share from continuing operations was CNY 0.1021 compared to CNY 0.1131 a year ago. Diluted earnings per share from continuing operations was CNY 0.1021 compared to CNY 0.0986 a year ago. Basic earnings per share was CNY 0.1259 compared to CNY 0.1366 a year ago.

Diluted earnings per share was CNY 0.1259 compared to CNY 0.1215 a year ago.